Exploring the Combined Action of Adding Pertuzumab to Branded Trastuzumab Versus Trastuzumab Biosimilars for Treating HER2+ Breast Cancer
International Journal of Molecular Sciences（2024）
Key words
HER2(+) breast cancer,monoclonal antibodies,trastuzumab biosimilars
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined